Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial.
Thornton PS, Maniatis AK, Aghajanova E, Chertok E, Vlachopapadopoulou E, Lin Z, Song W, Christoffersen ED, Breinholt VM, Kovalenko T, Giorgadze E, Korpal-Szczyrska M, Hofman PL, Karpf DB, Shu AD, Beckert M. Thornton PS, et al. Among authors: christoffersen ed. J Clin Endocrinol Metab. 2021 Oct 21;106(11):3184-3195. doi: 10.1210/clinem/dgab529. J Clin Endocrinol Metab. 2021. PMID: 34272849 Free PMC article. Clinical Trial.
Response to Letter to the Editor From L. Sävendahl et al: "Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial".
Thornton PS, Maniatis AK, Aghajanova E, Chertok E, Vlachopapadopoulou E, Lin Z, Song W, Christoffersen ED, Breinholt VM, Kovalenko T, Giorgadze E, Korpal-Szczyrska M, Hofman PL, Karpf DB, Shu AD, Beckert M. Thornton PS, et al. Among authors: christoffersen ed. J Clin Endocrinol Metab. 2022 Feb 17;107(3):e1333-e1334. doi: 10.1210/clinem/dgab738. J Clin Endocrinol Metab. 2022. PMID: 34626470 Free PMC article. No abstract available.
Response to Letter to the Editor From Malozowski: "Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial".
Thornton PS, Maniatis AK, Aghajanova E, Chertok E, Lin Z, Song W, Christoffersen ED, Breinholt VM, Giorgadze E, Korpal-Szczyrska M, Hofman PL, Karpf DB, Shu AD, Beckert M. Thornton PS, et al. Among authors: christoffersen ed. J Clin Endocrinol Metab. 2022 Apr 19;107(5):e2215-e2216. doi: 10.1210/clinem/dgab879. J Clin Endocrinol Metab. 2022. PMID: 34915563 Free PMC article. No abstract available.
A first-in-man phase 1 trial for long-acting TransCon Growth Hormone.
Gilfoyle D, Mortensen E, Christoffersen ED, Leff JA, Beckert M. Gilfoyle D, et al. Among authors: christoffersen ed. Growth Horm IGF Res. 2018 Apr;39:34-39. doi: 10.1016/j.ghir.2017.12.002. Epub 2017 Dec 5. Growth Horm IGF Res. 2018. PMID: 29273485 Clinical Trial.
A phase 2 trial of long-acting TransCon growth hormone in adult GH deficiency.
Höybye C, Pfeiffer AF, Ferone D, Christiansen JS, Gilfoyle D, Christoffersen ED, Mortensen E, Leff JA, Beckert M. Höybye C, et al. Among authors: christoffersen ed. Endocr Connect. 2017 Apr;6(3):129-138. doi: 10.1530/EC-17-0007. Epub 2017 Feb 14. Endocr Connect. 2017. PMID: 28196799 Free PMC article.